Understanding precisely how Treg cell function may be altered in HIV-infected subjects is of importance in the context of determining if this increasingly important subset of CD4 T cells represents a reasonable target for immune-based therapy in HIV infection, and if such therapy would be appropriate at all stages of HIV disease. The gene discussed is CD4; the disease is HIV infectious disease.